乳酸清除率对体外心肺复苏的院外心脏骤停患者临床与神经结局的影响:二次数据分析
该回顾性多中心观察研究纳入2013年1月1日至2018年12月31日在日本36家医院接受ECPR的1227例院外心脏骤停患者,乳酸于急诊科入院时首次评估、随后第二次测量,并计算改良6小时乳酸清除率。按改良6小时乳酸清除率四分位分组,30天生存率随清除率升高而增加(Q1 21.2%、Q2 36.8%、Q3 41.4%、Q4 53.6%,趋势P<0.001)。多因素分析显示,改良6小时乳酸清除率与30天生存率(校正OR 1.003,95%CI 1.001-1.005,P<0.001)及良好神经结局(校正OR 1.002,95%CI 1.000-1.004,P=0.027)显著相关。作者认为乳酸清除率可作为评估是否继续ECPR的标准。
要点
- 接受ECPR的院外心脏骤停患者中,改良6小时乳酸清除率四分位越高,30天生存率越高:Q1 21.2%、Q2 36.8%、Q3 41.4%、Q4 53.6%,趋势P<0.001。
- 多因素分析显示,改良6小时乳酸清除率与30天生存率独立相关(校正OR 1.003,95%CI 1.001-1.005,P<0.001)。
- 改良6小时乳酸清除率与良好神经结局相关(校正OR 1.002,95%CI 1.000-1.004,P=0.027)。
- 作者认为乳酸清除率可作为评估是否继续ECPR的标准。
适用人群与场景
- 2013年1月1日至2018年12月31日在日本36家医院接受ECPR的院外心脏骤停患者,共1227例。
- 纳入患者均在急诊科入院时首次评估乳酸、随后第二次测量乳酸。
诊断标准与关键阈值
- 改良6小时乳酸清除率定义为:([初始乳酸-第二次乳酸]/初始乳酸)×100×(6/初始与第二次测量间隔时间[小时])。
- 按改良6小时乳酸清除率四分位等分为四组:Q1(乳酸清除率<18.8)、Q2(18.8<乳酸清除率<59.9)、Q3(60.0<乳酸清除率<101.2)、Q4(乳酸清除率>101.2)。
研究设计与关键结果
- 研究类型:回顾性多中心观察研究,二次数据分析;样本量1227例,日本36家医院;干预:无。
- 30天生存率随改良6小时乳酸清除率升高而增加:Q1 21.2%、Q2 36.8%、Q3 41.4%、Q4 53.6%,趋势P<0.001。
- 多因素分析:改良6小时乳酸清除率与30天生存率显著相关(校正OR 1.003,95%CI 1.001-1.005,P<0.001)。
- 多因素分析:改良6小时乳酸清除率与良好神经结局显著相关(校正OR 1.002,95%CI 1.000-1.004,P=0.027)。
证据类型、等级与局限
- 证据类型:回顾性多中心观察研究(二次数据分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在接受ECPR的院外心脏骤停患者中,乳酸清除率可作为评估是否继续ECPR的标准。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Serial evaluations of lactate concentration may be more useful in predicting outcomes in patients with out-of-hospital cardiac arrest (OHCA) than a single measurement. This study aimed to evaluate the impact of lactate clearance (LC) on clinical and neurologic outcomes in patients with OHCA who underwent extracorporeal cardiopulmonary resuscitation (ECPR).
DESIGN: Retrospective multicenter observational study.
SETTING: Patients with OHCA receiving ECPR at 36 hospitals in Japan between January 1, 2013, and December 31, 2018.
PATIENTS: This study evaluated 1227 patients, with lactate initial assessed upon emergency department admission and lactate second measured subsequently. To adjust for the disparity in the time between lactate measurements, the modified 6-hour LC was defined as follows: ([lactate initial -lactate second ]/lactate initial ) × 100 × (6/the duration between the initial and second measurements [hr]). The patients were divided into four groups according to the modified 6-hour LC with an equivalent number of patients among LC quartiles: Q1 (LC < 18.8), Q2 (18.8 < LC < 59.9), Q3 (60.0 < LC < 101.2), and Q4 (101.2 < LC).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The 30-day survival rates increased as the 6-hour LC increased (Q1, 21.2%; Q2, 36.8%; Q3, 41.4%; Q4, 53.6%; p for trend < 0.001). In the multivariate analysis, the modified 6-hour LC was significantly associated with a 30-day survival rate (adjusted odds ratio [AOR], 1.003; 95% CI, 1.001-1.005; p < 0.001) and favorable neurologic outcome (AOR, 1.002; 95% CI, 1.000-1.004; p = 0.027).
CONCLUSIONS: In patients with OHCA who underwent ECPR, an increase in the modified 6-hour LC was associated with favorable clinical and neurologic outcome. Thus, LC can be a criterion to assess whether ECPR should be continued.
参考来源
- Sugimoto M, Takayama W, Inoue A, et al. Impact of Lactate Clearance on Clinical and Neurological Outcomes of Patients With Out-of-Hospital Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation: A Secondary Data Analysis. Crit Care Med. 2024. PMID: 38411442. doi:10.1097/CCM.0000000000006245
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。